Daniel Weisdorf Selected Research

Myelodysplastic Syndromes (Myelodysplastic Syndrome)

11/2021	Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes.
11/2021	Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults.
1/2021	Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study.
1/2020	Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study.
1/2019	Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.
9/2017	Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.
2/2016	Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 Years.
11/2012	Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning.
2/2011	Review of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and Medicaid Services.
1/2009	Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Weisdorf Research Topics

Disease

28	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 11/2002
27	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2007
16	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 01/2002
16	Leukemia 09/2021 - 02/2006
15	Neoplasms (Cancer) 10/2022 - 03/2004
13	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 07/2007
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021 - 10/2007
10	Bronchiolitis Obliterans Syndrome 10/2022 - 11/2005
7	Multiple Myeloma 12/2020 - 03/2004
6	Infections 10/2022 - 01/2003
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 03/2004
5	Residual Neoplasm 07/2017 - 11/2005
4	Chromosome Aberrations (Chromosome Abnormalities) 10/2022 - 01/2020
3	Stomatitis 01/2021 - 06/2004
3	Lymphoma (Lymphomas) 01/2021 - 09/2006
3	COVID-19 01/2021 - 01/2020
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 04/2012
3	Pathologic Complete Response 01/2020 - 09/2013
2	Neutropenia 01/2021 - 10/2015
2	Systemic Mastocytosis 01/2016 - 10/2014
1	Hyperammonemia 01/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Calculi (Calculus) 01/2021
1	Frailty 01/2021
1	Viremia 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	monosomy Chromosome 7 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Cardiotoxicity 01/2017
1	Myeloid Leukemia (Leukemia, Myelocytic) 06/2012
1	Communicable Diseases (Infectious Diseases) 03/2012
1	Overweight 12/2011
1	Disease Progression 12/2011
1	Obesity 12/2011
1	Chromosomal Instability (Chromosome Stability) 09/2011
1	Aneuploidy (Aneuploid) 09/2011
1	Hypertension (High Blood Pressure) 02/2007
1	Nausea 09/2006
1	Hypotension (Low Blood Pressure) 09/2006
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 07/2006

Drug/Important Bio-Agent (IBA)

6	SteroidsIBA 10/2022 - 10/2004
5	fludarabineIBA 01/2022 - 11/2010
5	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 12/2005
4	Core Binding Factors (Core-Binding Factor)IBA 01/2021 - 12/2014
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 03/2004
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 11/2010
3	Melphalan (Alkeran)FDA LinkGeneric 11/2021 - 12/2011
3	Busulfan (Busulfex)FDA Link 11/2021 - 01/2018
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 10/2012
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 04/2012
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 08/2005
3	LigandsIBA 09/2015 - 08/2006
3	Rituximab (Mabthera)FDA Link 10/2012 - 10/2007
2	Fibroblast Growth Factor 7 FDA Link 01/2021 - 12/2004
2	KIR ReceptorsIBA 01/2019 - 08/2006
2	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2018 - 06/2013
2	Interleukin-15 (Interleukin 15)IBA 04/2018 - 01/2018
2	Sorafenib (BAY 43-9006)FDA Link 04/2018 - 01/2018
2	trans-crotonin (CTN)IBA 01/2017 - 12/2011
2	plerixafor FDA Link 02/2009 - 03/2004
2	ProMune (CpG 7909)IBA 10/2007 - 09/2006
2	HLA-A Antigens (HLA-A)IBA 08/2006 - 10/2004
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Filgrastim (Neupogen)FDA Link 01/2021
1	Foscarnet FDA LinkGeneric 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Biosimilar PharmaceuticalsIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Clofarabine (Clolar)FDA Link 10/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2017
1	Nerve Growth Factor (NGF)IBA 10/2015
1	Lenalidomide (CC 5013)FDA Link 08/2014
1	Biological ProductsIBA 12/2011
1	Interleukin-2 (IL2)IBA 11/2010
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2010
1	Toll-Like Receptor 9IBA 10/2007
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2007
1	OligodeoxyribonucleotidesIBA 09/2006
1	CPG-oligonucleotideIBA 09/2006
1	HLA-B Antigens (HLA-B)IBA 08/2006

Therapy/Procedure

45	Cell Transplantation 10/2022 - 12/2005
33	Transplantation 10/2022 - 01/2002
31	Therapeutics 01/2022 - 06/2004
25	Hematopoietic Stem Cell Transplantation 01/2022 - 12/2004
11	Drug Therapy (Chemotherapy) 09/2021 - 06/2004
7	Homologous Transplantation 11/2021 - 11/2012
7	Stem Cell Transplantation 12/2011 - 06/2006
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2014 - 11/2002
1	Patient Readmission 01/2021
1	Induction Chemotherapy 01/2020
1	Length of Stay 01/2019
1	Haploidentical Transplantation 06/2012
1	Autologous Transplantation 12/2011
1	Catheters 09/2006
1	Intravenous Infusions 09/2006